AnandRathi

Cohance Lifesciences Ltd Fundamental Analysis

Last Updated Date: 16 Oct 2026
₹463.95
+4.90 (+1.07%)

Cohance Lifesciences Ltd (Cohance Life) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹17,751 crore.

Cohance Lifesciences Ltd Overview

Market cap₹17,751 Crs
Volume17,362
Prev. Close₹459.05
Year range₹267.85 - ₹917.50
ISININE03QK01018

Cohance Lifesciences Ltd Fundamentals

ROCE(TTM)7.27%
P/E Ratio (TTM)99.99
P/B Ratio3.96
Debt to Equity0.03
ROE5.11%
EPS (TTM)5.00
Dividend Yield0.00%
Book Value117.10
Profit Margin10.03%
Operating Margin12.59%

Cohance Lifesciences Ltd Historical Performance

1 Month Return7.09%
6 Month Return27.72%
3 Year Return-20.17%
3 Month Return4.80%
1 Year Return-48.34%
5 Year Return-12.80%

Cohance Lifesciences Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research